Bristol Myers Squibb BMY
NYSE BMY
$61.17 -0.51 (-0.83%)
As of: Oct 21, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) Other Non-Current Assets (2009 - 2026)

Updated

Bristol Myers Squibb's Other Non-Current Assets was $6.38 billion in Q2 2026, up 7.4% from $5.94 billion a year earlier and up 4.9% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Other Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Assets at Bristol Myers Squibb came in at $6.47 billion, up 6.0% from FY2024.

  • Other Non-Current Assets has now increased for three consecutive years, though with a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Assets was $6.11 billion in FY2024 (+13.7%), $5.37 billion in FY2023 (+8.7%), $4.94 billion in FY2022 (-10.7%) and $5.54 billion in FY2021 (-21.1%).
  • Quarterly Other Non-Current Assets has moved between $53 million (Q1 2023) and $6.47 billion (Q4 2025) over five years.
  • Compared with a year earlier, Other Non-Current Assets has increased for four straight quarters, with growth averaging 4.4% over the last seven quarters.
  • The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2024 (growth of 13.7%); the worst was Q1 2022 (a decline of 97.1%).
  • Per Business Quant data, BMY's Other Non-Current Assets in the three quarters before Q2 2026 was $6.08 billion (Q1 2026), $6.47 billion (Q4 2025) and $6.33 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Bristol Myers Squibb 125.02 Bn 76.29 Bn 9.25 Bn 6.38 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.38 Bn
Mar 31, 2026 6.08 Bn
Dec 31, 2025 6.47 Bn
Sep 30, 2025 6.33 Bn
Jun 30, 2025 5.94 Bn
Mar 31, 2025 5.87 Bn
Dec 31, 2024 6.11 Bn
Sep 30, 2024 6.04 Bn
Jun 30, 2024 6.07 Bn
Mar 31, 2024 6.02 Bn
Dec 31, 2023 5.37 Bn
Sep 30, 2023 54.00 Mn
Jun 30, 2023 53.00 Mn
Mar 31, 2023 53.00 Mn
Dec 31, 2022 4.94 Bn
Sep 30, 2022 223.00 Mn
Jun 30, 2022 210.00 Mn
Mar 31, 2022 210.00 Mn
Dec 31, 2021 5.54 Bn
Sep 30, 2021 339.00 Mn
API Access

Bristol Myers Squibb Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BMY&period=max&api_key=YOUR_API_KEY